ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (0LB2)

55.00
0.00
( 0.00% )
Updated: 20:00:00

Supernus Pharmaceuticals Inc Financial Summary

The current 0LB2 market cap is 3B. The company's latest EPS is USD 0.0241 and P/E is 1192.12.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 392.76M520.4M586.31M667.75M609.04M
Operating Income 148.57M173.7M86.03M46.12M-5.27M
Net Income 113.06M126.95M53.42M60.71M1.32M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.16B1.5B1.69B1.7B1.28B
Total Liabilities 564.85M759.24M873.3M816.3M356.16M
Total Equity 595.43M744.86M815.85M886.2M921.52M

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 143.13M138.4M127.13M116.83M111.09M
Investing -157.92M-34.7M-81.91M-216.66M268.73M
Financing 3.93M3.56M-130.42M-10.48M-397.88M
Market Cap 3B
Price to Earnings Ratio 1192.12
Price to Sales Ratio 2.58
Price to Cash Ratio 20.91
Price to Book Ratio 1.7
Dividend Yield -

Share Statistics

Shares Outstanding 54.63M
Average Volume (1 week) 27
Average Volume (1 Month) 96
52 Week Change 0.00%
52 Week High 55.00
52 Week Low 55.00
Spread (Intraday) 0 (0%)

Company Info

Company Name Supernus Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.supernus.com
Industry pharmaceutical preparations (2834)